Telehealth-Supported Breastfeeding Counseling in Primiparous Mothers
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorMarmara University
About this trial
Breastfeeding is critical for infant and maternal health; however, many first-time mothers experience difficulties that may lead to early discontinuation of breastfeeding. Telehealth-supported breastfeeding counseling has the potential to provide timely, accessible, and continuous support to mothers during the postpartum period.
This randomized controlled trial aims to evaluate the effect of telehealth-supported breastfeeding counseling on breastfeeding duration, breastfeeding self-efficacy, and postpartum depressive symptoms in primiparous mothers. Participants will be randomly assigned to either a telehealth-supported breastfeeding counseling group or a routine postpartum care group.
The intervention group will receive structured breastfeeding counseling sessions delivered via telecommunication tools in addition to standard care, while the control group will receive routine postpartum care only. Outcomes will be assessed using validated questionnaires and follow-up evaluations during the postpartum period. The findings of this study may contribute to improving breastfeeding support strategies and maternal mental health outcomes.
Eligibility criteria
Qualifiers
Primiparous women aged 18-45 years.
Mothers who have delivered a healthy, term (≥37 weeks), singleton infant.
Ability to communicate in Turkish.
Willingness to participate in the study and provide informed consent.
Disqualifiers
Mothers with severe maternal medical or psychiatric conditions that may interfere with breastfeeding.
Infants with congenital anomalies or conditions affecting feeding.
Mothers who require neonatal intensive care admission for their infants.
Mothers who are unable to participate in telehealth follow-up.
Trial design
Treatments tested in this trial
- Telehealth-Supported Breastfeeding Counseling
- Routine Postpartum Care
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov